Ironwood Pharmaceuticals | IRWD - Loan Capital


Ironwood Pharmaceuticals reported $583.99M in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 48.25M 609K Dec/2025
Almirall EUR 324.81M 61.32M Dec/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Ardelyx USD 202.83M 696K Dec/2025
Astellas Pharma JPY 320B 0 Mar/2026
AstraZeneca USD 26.14B 19.58B Dec/2025
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Coherus Biosciences USD 51.08M 496K Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Lexicon Pharmaceuticals USD 49.41M 7.1M Dec/2025
MacroGenics USD 70M 256K Dec/2025
Moderna USD 610M 584M Dec/2025
Myriad Genetics USD 119.9M 400K Dec/2025
Pacira USD 372.19M 4.53M Dec/2025
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Takeda JPY 4.27T 81.29B Dec/2025
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024